Yi Zeng

3.6k total citations · 2 hit papers
78 papers, 2.9k citations indexed

About

Yi Zeng is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Yi Zeng has authored 78 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 22 papers in Oncology and 19 papers in Epidemiology. Recurrent topics in Yi Zeng's work include HIV Research and Treatment (17 papers), Viral-associated cancers and disorders (15 papers) and HIV/AIDS drug development and treatment (9 papers). Yi Zeng is often cited by papers focused on HIV Research and Treatment (17 papers), Viral-associated cancers and disorders (15 papers) and HIV/AIDS drug development and treatment (9 papers). Yi Zeng collaborates with scholars based in China, United States and France. Yi Zeng's co-authors include Guy de Thé, Cheryl A. Winkler, Hong‐Wen Deng, Jian Liao, Xiuchan Guo, Li Guan, Minzhong Tang, Stephen J. O’Brien, Wang Sheng and Ji Li and has published in prestigious journals such as PLoS ONE, Biomaterials and Chemical Communications.

In The Last Decade

Yi Zeng

76 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evaluation and Integration of Genetic Signature for Prediction Risk of Nasopharyngeal Carcinoma in Southern China

2014 607 citations Yi Zeng et al. profile →
Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer

2014 443 citations Xiongwei Deng, Minjun Cao et al. Biomaterials profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yi Zeng China	26	1.0k	863	594	409	316	78	2.9k
Ya‐Wen Cheng Taiwan	37	2.0k 1.9×	830 1.0×	1.0k 1.7×	536 1.3×	191 0.6×	124	3.9k
Zhe Zhang China	30	1.1k 1.1×	802 0.9×	587 1.0×	277 0.7×	62 0.2×	121	2.6k
Lu Jiang China	35	2.0k 1.9×	470 0.5×	1.0k 1.8×	257 0.6×	97 0.3×	183	4.4k
Dan Zhao China	37	1.7k 1.6×	976 1.1×	858 1.4×	337 0.8×	62 0.2×	249	4.2k
Zhao Huang China	28	2.1k 2.0×	931 1.1×	1.2k 1.9×	416 1.0×	95 0.3×	60	4.1k
Ala‐Eddin Al Moustafa Canada	27	798 0.8×	881 1.0×	337 0.6×	461 1.1×	45 0.1×	82	2.4k
Yili Wang China	27	862 0.8×	690 0.8×	368 0.6×	335 0.8×	237 0.8×	121	2.7k
Xuebing Li China	29	1.8k 1.7×	296 0.3×	819 1.4×	360 0.9×	375 1.2×	145	3.3k
Zhong Chen China	31	1.4k 1.3×	362 0.4×	591 1.0×	162 0.4×	118 0.4×	169	3.0k
Chen Yang China	31	1.9k 1.8×	999 1.2×	1.1k 1.8×	218 0.5×	138 0.4×	153	3.5k

Countries citing papers authored by Yi Zeng

Since Specialization

Citations

This map shows the geographic impact of Yi Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Zeng more than expected).

Fields of papers citing papers by Yi Zeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Zeng. The network helps show where Yi Zeng may publish in the future.

Co-authorship network of co-authors of Yi Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Zeng. A scholar is included among the top collaborators of Yi Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Zeng. Yi Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Hongxia, et al.. (2024). The current landscape and prospects of antibody-drug conjugates for lung cancer brain metastases: a narrative review. Translational Lung Cancer Research. 13(12). 3778–3794. 4 indexed citations

Wang, Xiaoli, Jiao Wang, Wenmei Zhang, et al.. (2018). Inhibition of Human Immunodeficiency Virus Type 1 Entry by a Keggin Polyoxometalate. Viruses. 10(5). 265–265. 11 indexed citations

Liu, Wei, Jiao Wang, Xiaoguang Zhang, et al.. (2018). A novel peptide shows excellent anti-HIV-1 potency as a gp41 fusion inhibitor. Bioorganic & Medicinal Chemistry Letters. 28(5). 910–914. 2 indexed citations

Chen, Danying, Xiaozhou He, Jingrong Ye, et al.. (2016). Genetic and Phenotypic Analysis of CRF01_AE HIV-1 env Clones from Patients Residing in Beijing, China. AIDS Research and Human Retroviruses. 32(10-11). 1113–1124. 6 indexed citations

Wang, Shunyi, et al.. (2016). Comparison of three quantification methods for the TZM-bl pseudovirus assay for screening of anti-HIV-1 agents. Journal of Virological Methods. 233. 56–61. 20 indexed citations

Zhang, Fang, Xuebin Chen, Xin Jing, et al.. (2016). miR-100 suppresses the proliferation and tumor growth of esophageal squamous cancer cells via targeting CXCR7. Oncology Reports. 35(6). 3453–3459. 28 indexed citations

Guo, Ying, Zhijing Wang, Rong Li, et al.. (2015). GALC gene is downregulated by promoter hypermethylation in Epstein-Barr virus-associated nasopharyngeal carcinoma. Oncology Reports. 34(3). 1369–1378. 5 indexed citations

Tan, Jianjun, Min Su, Yi Zeng, & Cunxin Wang. (2015). Design, synthesis and activity evaluation of novel peptide fusion inhibitors targeting HIV-1 gp41. Bioorganic & Medicinal Chemistry. 24(2). 201–206. 7 indexed citations

Ye, Jingrong, Hongyan Lu, Ruolei Xin, et al.. (2014). Phylogenetic and Temporal Dynamics of Human Immunodeficiency Virus Type 1B in China: Four Types of B Strains Circulate in China. AIDS Research and Human Retroviruses. 30(9). 920–926. 12 indexed citations

10.

Deng, Xiongwei, Minjun Cao, Jiakun Zhang, et al.. (2014). Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer. Biomaterials. 35(14). 4333–4344. 443 indexed citations breakdown →

11.

Zhang, Fang, Zhiping Yang, Minjun Cao, et al.. (2013). MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer. Cancer Letters. 342(1). 121–129. 74 indexed citations

12.

Ye, Jingrong, Ruolei Xin, Hongyan Lu, et al.. (2013). Phylogenetic and Temporal Dynamics of Human Immunodeficiency Virus Type 1 CRF01_AE in China. PLoS ONE. 8(1). e54238–e54238. 21 indexed citations

13.

Liu, Hongwei, et al.. (2013). Statistical analysis of human papillomavirus in a subset of upper aerodigestive tract tumors. Journal of Medical Virology. 85(10). 1775–1785. 29 indexed citations

14.

Jin, Rui, Pengxiang Zhao, Xuemei Ma, et al.. (2013). Quantification of Epstein-Barr Virus DNA in Patients with Idiopathic Orbital Inflammatory Pseudotumor. PLoS ONE. 8(1). e50812–e50812. 12 indexed citations

15.

Ye, Jingrong, et al.. (2011). Genetic Diversity of HIV Type 1 Isolated from Newly Diagnosed Subjects (2006–2007) in Beijing, China. AIDS Research and Human Retroviruses. 28(1). 119–123. 12 indexed citations

16.

Ye, Xiangyang, et al.. (2010). [Genetic characteristics of HIV-1 CRF01_AE strains circulating in Beijing].. PubMed. 31(11). 1231–4. 1 indexed citations

17.

Li, Shuying, et al.. (2010). Meta-analysis of the relationship between Epstein-Barr virus infection and clinicopathological features of patients with gastric carcinoma. Science China Life Sciences. 53(4). 524–530. 31 indexed citations

18.

Qin, Di, Yi Zeng, Chao Qian, et al.. (2008). Induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1: involvement of IL-10 and IL-4. Cellular Microbiology. 10(3). 713–728. 32 indexed citations

19.

Jia, Wei-Hua, Qi-Hong Huang, Jian Liao, et al.. (2006). Trends in incidence and mortality of nasopharyngeal carcinoma over a 20–25 year period (1978/1983–2002) in Sihui and Cangwu counties in southern China. BMC Cancer. 6(1). 178–178. 176 indexed citations

20.

Ma, Xuemei, et al.. (2005). Clinical Laboratories on a Chip for Human Immunodeficiency Virus Assay. PubMed. 49. 1274–1277. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact